You are in: eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Toxicology Toxicity, Marine - Histamine In FishArticle Last Updated: Feb 8, 2008AUTHOR AND EDITOR INFORMATIONAuthor: Daniel Noltkamper, MD, FACEP, Medical Director, Department of Emergency Medicine, Naval Hospital of Camp Lejeune Daniel Noltkamper is a member of the following medical societies: American College of Emergency Physicians Editors: William T Zempsky, MD, Associate Director, Assistant Professor, Department of Pediatrics, Division of Pediatric Emergency Medicine, University of Connecticut and Connecticut Children's Medical Center; Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc; Jeffrey R Tucker, MD, Assistant Professor, Department of Pediatrics, Division of Emergency Medicine, University of Connecticut and Connecticut Children's Medical Center; Paul D Petry, DO, FACOP, FAAP, Consulting Staff, Freeman Pediatric Care, Freeman Health System; Timothy E Corden, MD, Associate Professor of Pediatrics, Co-Director, Policy Core, Injury Research Center, Medical College of Wisconsin; Associate Director, PICU, Children's Hospital of Wisconsin Author and Editor Disclosure Synonyms and related keywords: histamine, fish poisoning, pseudoallergic fish poisoning, scombroid fish poisoning, histamine overdose, mahi-mahi flush, mahi-mahi, dolphin fish, amberjack, herring, sardine, anchovy, bluefish, fish ingestion, histamine fish poisoning, Escherichia coli, Proteus, Klebsiella, saurine, coronary artery disease, tachycardia, hypotension, conjunctival injection, bronchospasm, angioedema, urticaria, foreign body aspiration INTRODUCTIONBackgroundHistamine fish poisoning, an entirely preventable condition, is among the most common toxicities related to fish ingestion. Histamine fish poisoning, which had been previously termed scombroid fish poisoning, pseudoallergic fish poisoning, histamine overdose, or mahi-mahi flush, accounts for 5% of all food-borne outbreaks reported to the Centers for Disease Control and Prevention (CDC) and 37% of all seafood-related food-borne illnesses. Histamine fish poisoning presents as a possible allergic reaction after consuming certain fish but is actually caused by ingesting toxins within the fish's tissues.1 The term scombroid, derived from the Greek word scombros (meaning mackerel or tunny), is the basis for the family name Scombridae, which includes mackerel, tuna, marlin, swordfish, albacore, bonito, skipjack, and almost 100 other species. Because the first fish species implicated in this poisoning were from the suborder Scombroidea, the toxicity was originally termed scombroid toxicity or scombroid fish poisoning. The term histamine fish poisoning is now considered more appropriate because most poisonings relate to nonscombroid fish (eg, mahi-mahi [dolphin fish], amberjack, herring, sardine, anchovy, bluefish). PathophysiologyThe poisoning directly relates to improper preservation and inadequate refrigeration. Histidine decarboxylase (HDC), found in Escherichia coli and in Proteus and Klebsiella species, converts histidine, present in fish tissue, to histamine. These bacteria also live on fish tissue. Without adequate cooling (eg, leaving fish at room temperature for 12 h), these bacteria multiply, increasing the histidine-to-histamine conversion rate and raising histamine levels from 0.1 mg/100 g in a healthy fish to 100 mg/100 g. Toxic levels are estimated at 20-50 mg/100 g. Elevated histamine levels in the urine of patients and elevated histamine levels in the tissue of the fish confirm that histamine is the causative agent.2 Antihistamines traditionally relieve the symptoms and support histamine as the causative agent. Some theorize a second agent in fish tissues may play a role because attempts to recreate the symptoms by orally feeding people histamine have failed. Histamine is poorly absorbed in the GI tract, and the liver and intestinal mucosa can deactivate histamines. This second causative agent, possibly saurine (histamine hydrochloride), may enhance the activity of histamine, facilitate its absorption, or prevent its inactivation by histamine N-methyltransferase or diamine oxidase. Others postulate that cadaverine or putrescine may be the second agent. FrequencyUnited StatesThe CDC reported approximately 200 outbreaks of scombroid poisoning involving nearly 1400 people from 1973-87.3 Between 1988-1997, 145 reported outbreaks involved 811 persons in 20 states.3 These numbers are increasing with the promotion of fish as a healthy alternative to meat. Most outbreaks have occurred in Hawaii, Florida, California, Washington, New York, and Connecticut, although outbreaks may occur anywhere that has easy access to fresh fish. InternationalThe implicated fish live in temperate or tropical waters, making populations on adjacent land areas more likely to experience outbreaks. Mortality/MorbidityMortality has become rare. Patients with comorbid illnesses such as coronary artery disease risk acute coronary syndromes caused by the tachycardia and hypotension associated with severe cases of scombroid poisoning. RaceAll races are equally affected. SexFemales and males are equally susceptible to histamine fish poisoning. AgeHistamine fish poisoning equally affects all ages. CLINICALHistoryMost patients present within 15-60 minutes of toxin ingestion. The uneven distribution of decay may cause different symptoms among people who ate the same fish.
PhysicalThe initial physical presentation easily can be mistaken for an allergic reaction if the history of fish ingestion is not obtained. Physical signs include the following:
CausesHistamine fish poisoning occurs despite cooking, smoking, or canning the fish. Toxin production occurs when inadequate refrigeration allows bacteria-containing histidine decarboxylase to act. This converts histidine in the fish tissues to histamine. Because bacterial decay of the fish is uneven, symptoms may depend on the amount eaten or the specific part of the fish consumed.
DIFFERENTIALSBurns, Thermal Carcinoid Tumor Food Poisoning Pheochromocytoma Sunburn Toxic Shock Syndrome Toxicity, Marine - Ciguatera Toxicity, Seafood Zollinger-Ellison Syndrome
|
| Drug Name | Diphenhydramine (Benadryl) |
|---|---|
| Description | H1 blocker, considered the DOC. For symptomatic relief of symptoms caused by release of histamine in allergic reactions. |
| Adult Dose | 25-50 mg PO/IM/IV q6h |
| Pediatric Dose | 5 mg/kg/d PO/IV/IM divided q6h; not to exceed 300 mg/d 1-2 mg/kg IV prn for patients with significant reactions |
| Contraindications | Documented hypersensitivity |
| Interactions | Potentiates effect of CNS depressants; some liquid preparations contain alcohol, caution if taking medications that can cause disulfiramlike reactions (eg, metronidazole) |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | May exacerbate angle-closure glaucoma, hyperthyroidism, peptic ulcer, or urinary tract obstruction; xerostomia may occur |
| Drug Name | Hydroxyzine (Vistaril, Atarax) |
|---|---|
| Description | Used to manage histamine-mediated pruritus; an alternative to diphenhydramine. Antagonizes H1 receptors in periphery. May suppress histamine activity in subcortical region of CNS. |
| Adult Dose | 25-50 mg PO/IM q6-8h |
| Pediatric Dose | <6 years: 50 mg/d PO/IM divided tid/qid >6 years: 100 mg/d PO/IM divided tid/qid |
| Contraindications | Documented hypersensitivity |
| Interactions | Potentiates effects of CNS depressants (eg, narcotics, barbiturates, ethanol) |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | May exacerbate angle-closure glaucoma, hyperthyroidism, peptic ulcer, or urinary tract obstruction; do not administer SC, intraarterial, or IV because thrombosis and digital gangrene can occur; may cause drowsiness |
| Drug Name | Famotidine (Pepcid) |
|---|---|
| Description | H2 antagonist that, when combined with an H1 type, may be useful in treating allergic reactions that do not respond to H1 antagonists alone. |
| Adult Dose | 20 mg PO/IV q12h |
| Pediatric Dose | 0.5 mg/kg/d PO/IV divided bid; not to exceed 40 mg/d |
| Contraindications | Documented hypersensitivity |
| Interactions | Decreases bioavailability of ketoconazole and itraconazole |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | If changes in renal function occur during therapy, consider adjusting dose or discontinuing treatment |
| Drug Name | Ranitidine (Zantac) |
|---|---|
| Description | A competitive, reversible inhibitor of histamine at the H2 receptor. H2 antagonist that, when combined with an H1 type, may be useful in treating allergic reactions that do not respond to H1 antagonists alone. |
| Adult Dose | 150 mg PO q12h 50 mg IV/IM q6-8h |
| Pediatric Dose | 4-5 mg/kg/d PO divided q8-12h; not to exceed 300 mg/d 2-4 mg/kg/d IV divided q6-8h; not to exceed 150 mg/d |
| Contraindications | Documented hypersensitivity |
| Interactions | >400 mg/d may decrease metabolism of warfarin, thus increasing effect; decreases bioavailability of ketoconazole and itraconazole |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | Caution in renal or liver impairment; if changes in renal function occur during therapy, consider adjusting dose or discontinuing treatment |
| Drug Name | Cimetidine (Tagamet) |
|---|---|
| Description | H2 antagonist that, when combined with an H1 type, may be useful in treating allergic reactions that do not respond to H1 antagonists alone. |
| Adult Dose | 300 mg PO/IV/IM q6-8h |
| Pediatric Dose | <16 years: 20-40 mg/kg/d PO/IV/IM divided q6h (dosage based on limited experience) |
| Contraindications | Documented hypersensitivity |
| Interactions | Reduces metabolism of warfarin, phenytoin, propranolol, nifedipine, diazepam, lidocaine, some tricyclic antidepressants, theophylline, and metronidazole; decreases bioavailability of ketoconazole and itraconazole |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | Modify doses in renal or hepatic impairment; rapid IV administration may cause hypotension or arrhythmias; CNS toxicity may occur in elderly persons or debilitated patients |
These agents elicit anti-inflammatory and immunosuppressive properties and cause profound and varied metabolic effects. They modify the body's immune response to certain stimuli.
| Drug Name | Methylprednisolone (Solu-Medrol) |
|---|---|
| Description | A glucocorticoid, which ameliorates delayed effects of anaphylactoid reactions and may limit biphasic anaphylaxis. |
| Adult Dose | 40-250 mg IV q4-6h; alternatively, 10-80 mg IM qd |
| Pediatric Dose | 0.5-1.7 mg/kg/d PO/IV/IM divided q6-12h |
| Contraindications | Documented hypersensitivity; may potentiate a systemic fungal infection; may mask signs and symptoms of any systemic infection |
| Interactions | Phenobarbital, phenytoin, and rifampin may increase metabolism of glucocorticoids, so consider increasing maintenance dosage |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Use in premature infants may lead to gasping syndrome caused by benzyl alcohol diluent |
These agents relax the bronchial smooth muscle to relieve bronchospasm.
| Drug Name | Albuterol (Proventil, Ventolin) |
|---|---|
| Description | DOC for bronchospasm. Stimulates adenyl cyclase to convert ATP to cAMP and causes bronchodilation. |
| Adult Dose | 2.5-5 mg inhaled via nebulizer q4-6h (may use continuously or repeatedly for initial relief of bronchospasm) To make solution, dilute 0.5 mL (2.5 mg) of 0.5% inhalation solution in 1-2.5 mL of 0.9% NaCl |
| Pediatric Dose | 2.5 mg inhaled via nebulizer q4-6h (may use continuously or repeatedly for initial relief of bronchospasm) |
| Contraindications | Documented hypersensitivity |
| Interactions | Beta-blockers may be inhibited as well as inhibit bronchodilatory effect of albuterol; tricyclic antidepressants and MAOIs may potentiate effect on vascular system; concomitant administration of sympathomimetics may exacerbate adverse cardiovascular effects. |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | May lower serum potassium level; may cause tachycardia, palpitations, or tremors |
Sympathomimetic agents produce direct or indirect stimulation of adrenergic receptors and have various actions depending on the specific receptors involved.
| Drug Name | Epinephrine (Adrenalin, EpiPen) |
|---|---|
| Description | DOC for emergency treatment of severe allergic reaction. Stimulates alpha-, beta1, and beta2-adrenergic receptors, which, in turn, results in bronchodilatation, increased peripheral vascular resistance, hypertension, increased chronotropic cardiac activity, and positive inotropic effects. |
| Adult Dose | 0.3-0.5 mg (0.3-0.5 mL 1:1000) IM/SC q15min; not to exceed 3-4 doses or q4h prn |
| Pediatric Dose | 0.01 mg/kg (0.01 mL/kg 1:1000) IM/SC q15min; not to exceed 3-4 doses or q4h prn; not to exceed 0.5 mg/dose (ie, 0.5 mL/dose) |
| Contraindications | None, if used for airway compromise |
| Interactions | Tricyclic antidepressants or MAOIs may potentiate effects; increases toxicity of beta- and alpha-blocking agents and that of halogenated inhalational anesthetics |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Caution in elderly persons, prostatic hypertrophy, hypertension, cardiovascular disease, diabetes mellitus, hyperthyroidism, and cerebrovascular insufficiency; rapid IV infusions may cause death from cerebrovascular hemorrhage or cardiac arrhythmias |
Toxicity, Marine - Histamine In Fish excerpt
Article Last Updated: Feb 8, 2008